phosphatidylserin
ps
molecul
present
cell
membran
activ
kept
inner
leaflet
cell
damag
move
surfac
becom
signal
remov
platform
upon
coagul
cascad
take
place
ligand
activ
feedback
cycl
inflammatori
cytokin
secret
initi
wakeup
call
innat
immun
respons
physiolog
respons
ps
ebola
viru
display
ps
molecul
membran
surfac
huge
number
virus
caus
patholog
inflammatori
cytokin
storm
hemorrhag
consumpt
coagulopathi
annexin
v
innat
molecul
cloak
membran
display
ps
prevent
cell
inflammatori
cytokin
gener
cascad
thrombin
gener
hypothesi
present
administr
cloak
ps
prevent
ebola
consumpt
coagulopathi
cytokin
storm
phosphatidylserin
ps
molecul
present
cell
membran
activ
kept
inner
leaflet
senesc
otherwis
damag
cell
ps
move
surfac
becom
signal
phagocyt
remov
platform
upon
coagul
cascad
take
place
ligand
receptor
helper
one
cell
activ
inflammatori
cytokin
secret
ligand
bind
tim
receptor
mononuclear
immun
cell
provid
wakeup
call
innat
immun
respons
billion
cell
becom
apoptot
daili
display
ps
surfac
rapidli
remov
phagocyt
recogn
cascad
gener
blood
coagul
innat
immun
activ
take
place
ebola
ps
surfac
viru
activ
inflammatori
cytokin
secret
ps
exposur
great
cytokin
storm
produc
thrombin
gener
cascad
ps
platform
gener
enough
thrombin
consum
coagul
compon
produc
hemorrhag
consumpt
coagulopathi
macrophag
dendrit
cell
phagocyt
secret
inflammatori
cytokin
tlr
surfac
recogn
foreign
damag
associ
molecular
pattern
also
display
receptor
ebola
receptor
bind
phagocyt
ps
virus
becom
infect
infect
cell
prime
viral
replic
gener
virus
infect
cell
addit
infect
dendrit
cell
may
longer
abl
mhc
present
antigen
pathogen
peptid
immun
cell
adapt
immun
respons
produc
immunolog
depress
discov
ps
ebola
viru
could
bind
receptor
cell
independ
produc
lethal
cytokin
storm
mice
proven
ebola
infect
knockout
neg
produc
cytokin
storm
mice
surviv
even
though
viral
load
minim
affect
hypothesi
present
annexin
v
therapeut
administr
ebola
prevent
cell
gener
inflammatori
cytokin
storm
stop
cascad
gener
hemorrhag
consumpt
coagulopathi
prevent
macrophag
dendrit
cell
infect
unfortun
annexin
v
cloak
ps
cascad
ca
nt
function
hemostasi
possibl
let
us
briefli
examin
compon
inflamm
blood
coagul
annexin
v
regard
possibl
administr
prevent
ebola
cytokin
storm
coagulopathi
without
caus
bleed
continu
late
mediat
inflammatori
respons
cell
damag
cytokin
becom
necrot
caus
high
mobil
group
box
one
molecul
releas
nuclear
disrupt
molecul
bind
receptor
dendrit
cell
caus
inflammatori
cytokin
secret
ps
expos
surfac
cell
damag
innat
late
mediat
inflammatori
respons
bind
receptor
cell
begin
feedback
cycl
inflammatori
cytokin
secret
expos
ps
amplifi
inflamm
amplifi
inflamm
damag
kill
pathogen
healthi
cell
ps
display
latter
activ
innat
immun
respons
infect
present
make
hemostasi
possibl
vascular
wall
breach
physiolog
ps
feedback
gener
contrast
patholog
cytokin
storm
hemorrhag
consumpt
coagulopathi
ebola
membran
display
ps
everi
viru
blood
coagul
begin
thrombin
must
present
gener
begin
cell
damag
procoagul
molecul
tissu
factor
tf
ps
expos
ebola
inflammatori
storm
damag
mani
cell
larg
number
tf
ps
molecul
expos
caus
intravascular
blood
coagul
consum
coagul
compon
lead
hemorrhag
consumpt
coagulopathi
tf
initi
blood
coagul
ps
platform
upon
coagul
cascad
thrombin
gener
produc
consumpt
coagulopathi
ebola
ps
expos
inflammatori
cell
damag
also
everi
viru
tf
begin
blood
coagul
activ
factor
x
ix
activ
factor
xa
chang
prothrombin
thrombin
factor
ixa
essenti
compon
coagul
cascad
tf
gener
thrombin
directli
indirectli
activ
coagul
compon
includ
coagul
cascad
activ
cascad
gener
thrombin
feedback
cycl
factor
x
activ
tenas
complex
catalyt
gener
thrombin
prothrombinas
complex
tenas
complex
activ
factor
viiia
ixa
bind
membran
display
ps
join
factor
x
activ
activ
factor
xa
join
factor
va
ps
prothrombinas
complex
factor
xa
factor
va
ps
amalgam
catalyt
begin
chang
prothrombin
thrombin
exponenti
increas
gener
make
hemostasi
possibl
hemophilia
factor
viii
andor
ix
avail
cascad
ca
nt
function
hemostasi
possibl
even
though
tf
thrombin
gener
affect
factor
ixa
requir
cascad
thrombin
gener
tf
ca
nt
suppli
enough
cascad
function
cascad
gener
thrombin
activ
factor
xi
activ
factor
ix
increas
thrombin
gener
exponenti
good
thing
though
fibrin
gener
desir
cellul
intravascular
blood
coagul
cascad
exponenti
thrombin
gener
take
place
factor
xii
must
activ
factor
xi
activ
factor
ix
factor
xii
must
activ
bind
sulfatid
activ
platelet
possibl
intravascularli
activ
platelet
secret
factor
xii
activ
inhibitor
possibl
vascular
breach
present
collagen
expos
platelet
display
sulfatid
ps
surfac
bind
collagen
blood
flow
wash
away
inhibitor
vascular
breach
tf
ps
expos
breach
site
factor
ix
activ
factor
xiia
make
cascad
exponenti
increas
thrombin
gener
possibl
thing
happen
atherosclerot
plaqu
ruptur
collagen
expos
physiolog
feedback
cycl
ps
exposur
caus
inflamm
thrombin
gener
need
assur
rapid
innat
immun
respons
infect
rapidli
control
bleed
vascular
wall
breach
cycl
like
atom
chain
reaction
danger
requir
control
propos
annexin
v
like
factor
ixa
one
follow
studi
park
support
hypothesi
annexin
v
block
cytokin
storm
consumpt
coagulopathi
studi
gram
neg
septicemia
induc
mice
lipopolysaccharid
lp
molecul
bacteria
gener
lethal
cytokin
storm
gener
excess
fibrin
coagulopathi
lp
gener
thrombin
bind
dendrit
cell
found
singl
inject
annexin
v
stop
cytokin
storm
reduc
fibrin
gener
enabl
mice
surviv
annexin
v
cloak
ps
damag
cell
block
bind
lp
let
us
take
brief
look
annexin
v
annexin
v
innat
molecul
found
cell
nano
molecular
amount
plasma
level
increas
inflamm
blood
coagul
cell
get
plasma
uncertain
small
protein
molecul
rapidli
remov
kidney
caus
halflif
minut
plasma
great
affin
ps
label
molecul
use
lab
clinic
identif
therapeut
applic
annexin
v
bind
ps
cell
membran
crystal
form
two
dimension
ps
cloak
shield
intern
cell
cytoplasm
annexin
v
cloak
ps
cell
inflammatori
cytokin
secret
caus
ebola
cytokin
storm
cascad
thrombin
gener
produc
hemorrhag
consumpt
coagulopathi
ca
nt
take
place
also
prevent
hemostasi
prevent
therapeut
use
use
annexin
v
treat
patholog
aspect
inflamm
blood
coagul
possibl
therapeut
benefit
rapid
long
last
patholog
one
transitori
physiolog
recoveri
ps
cloak
rapid
seem
possibl
annexin
v
cloak
expos
ps
instantli
perman
prevent
ps
abil
activ
cell
inflammatori
cytokin
secret
blood
coagul
ps
make
possibl
annexin
v
halflif
minut
mean
rapidli
elimin
ps
expos
subsequ
vascular
breach
met
breach
expos
tf
gener
thrombin
ps
sulfatid
activ
platelet
adher
collagen
regard
annexin
v
block
innat
immun
cell
activ
annexin
v
given
infect
innat
immun
respons
alreadi
initi
abil
monitor
effect
annexin
v
administr
would
desir
sinc
radio
floresc
label
annexin
v
molecul
use
lab
clinic
detect
ps
cell
possibl
use
quantifi
ps
cell
produc
inflamm
blood
coagul
could
condit
ebola
consid
annexin
v
treatment
inflammatori
coagul
patholog
present
sever
septicemia
present
ebola
ebola
littl
effect
treatment
annexin
v
may
effect
coronaviru
sar
sever
influenza
infect
lethal
condit
consid
annexin
v
therapi
lethal
respiratori
failur
may
result
inflamm
blood
coagul
caus
ps
exposur
infect
alveolar
bronchiolar
cell
result
consolid
air
space
massiv
infiltr
mix
mononuclearneutrophil
cell
edema
fibrin
deposit
administr
annexin
v
ebola
critic
ill
patient
probabl
intraven
bolu
cloak
ps
instantli
stop
cell
feedback
secret
inflammatori
cytokin
coagul
cascad
thrombin
gener
caus
inflammatori
organ
damag
thrombot
coagulopathi
ebola
bolu
administr
may
also
prevent
macrophag
dendrit
cell
infect
noncrit
sar
influenza
infect
monitor
level
ps
cell
could
use
determin
necess
annexin
v
use
need
ps
cell
count
use
monitor
continu
intraven
administr
annexin
v
abil
cloak
ps
block
role
inflamm
blood
coagul
well
document
therapeut
possibl
present
specul
requir
anim
studi
verif
present
littl
effect
treatment
lethal
condit
studi
would
seem
indic
author
declar
known
compet
financi
interest
person
relationship
could
appear
influenc
work
report
paper
